Levemir
Product Images NDC 0169-6432

Product Visual Gallery

This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Levemir (NDC 0169-6432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\smart\labeling\products\levemir\figures\chemical Structure.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 01)

Chemical structure diagram of Levemir showing the amino acid sequence with disulfide bonds and lipid modification present on the molecule.*

FDA Label Image

Figure 4a (Aa947266 E27c 432b 8e04 C36168d24ddb 06)

An instructional illustration showing a person holding a vial with one hand and removing the cap with the other hand. The image appears to be a step in the preparation or usage of a product, demonstrated by the hand actions.*

FDA Label Image

Figure 4b (Aa947266 E27c 432b 8e04 C36168d24ddb 07)

An instructional illustration showing two hands preparing a medication vial. One hand holds the vial, and the other hand is placing or removing a cap from the vial. The image is labeled '4B' in the top left corner.*

FDA Label Image

Figure 6 (Aa947266 E27c 432b 8e04 C36168d24ddb 08)

An instructional illustration showing a pair of hands handling a syringe. The top hand holds the syringe upright while the bottom hand pulls the protective cap straight downward to remove it. The image is labeled with the number 6 in a square in the top left corner.*

FDA Label Image

Figure 7 (Aa947266 E27c 432b 8e04 C36168d24ddb 09)

An instructional illustration showing a hand holding a vial and drawing liquid with a syringe. This diagram likely depicts the process of preparing an injectable medication by drawing it from a vial into a syringe.*

FDA Label Image

Figure 8 (Aa947266 E27c 432b 8e04 C36168d24ddb 10)

An instructional illustration showing hands holding a syringe and vial with an arrow indicating the syringe needle being inserted into the vial. This diagram is likely part of directions for preparing or administering Levemir insulin.*

FDA Label Image

Figure 9 (Aa947266 E27c 432b 8e04 C36168d24ddb 11)

An instructional illustration showing how to prepare an injection using a syringe and vial. It depicts a hand holding the vial inverted and another hand pulling back the syringe plunger to draw liquid from the vial. No text or specific product identifiers are visible.*

FDA Label Image

Figure 10 (Aa947266 E27c 432b 8e04 C36168d24ddb 12)

An instructional illustration showing a person holding a vial upside down and inserting a syringe needle into the vial, depicting the process of drawing medication from the vial. This image is related to administering Levemir, a product by Novo Nordisk.*

FDA Label Image

Figure 1 (Aa947266 E27c 432b 8e04 C36168d24ddb 13)

An instructional illustration showing a person injecting medication using a syringe into the skin of their abdomen. The drawing highlights proper technique for subcutaneous injection, with an arrow indicating the angle of insertion.*

FDA Label Image

Step 1 Fig B.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 28)

An instructional illustration showing hands wrapping or securing a bandage around a finger. An arrow indicates the direction for wrapping the bandage, emphasizing proper application technique. The figure is labeled as Figure B.*

FDA Label Image

Step 2 Fig C.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 29)

Illustration showing a hand holding a green and blue injection pen, likely representing a device for administering Levemir insulin. The image focuses on the pen’s dosing window and tip.*

FDA Label Image

Figure D (Aa947266 E27c 432b 8e04 C36168d24ddb 30)

Illustration showing hands removing caps from two Novo Nordisk insulin delivery devices named NoxoFine and NoxoFine Plus. The images depict the proper direction to pull the caps off by hand.*

FDA Label Image

Figure E (Aa947266 E27c 432b 8e04 C36168d24ddb 31)

Illustration showing the correct method to attach the NovoFine and NovoTwist needle components, likely for the Levemir insulin pen. It visually demonstrates how to connect the needle to the pen device with arrows indicating the direction of attachment.*

FDA Label Image

Figure F (Aa947266 E27c 432b 8e04 C36168d24ddb 32)

An instructional illustration showing how to attach a needle to the NovoFine or NovoFine Plus syringe (left) with a twisting motion, and how to attach a needle to the NovoTwist syringe (right) by pushing it on straight. Both illustrations depict hands handling the syringes and needles against a light background.*

FDA Label Image

Figure G (Aa947266 E27c 432b 8e04 C36168d24ddb 33)

An instructional illustration showing two steps for using NovoFine, NovoFine Plus, and NovoTwist needles with a syringe. The left panel demonstrates attaching the needle by pushing it straight onto the syringe, and the right panel shows securing the NovoTwist needle by twisting it onto the syringe.*

FDA Label Image

Step 7 Fig H.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 34)

An instructional illustration showing two hands adjusting the dose on a dial-type injector pen. The dial window displays the number 2, indicating 2 units selected. The image includes a curved arrow indicating a twisting motion, demonstrating how to select the dose on the device.*

FDA Label Image

Step 8 Fig I.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 35)

An instructional illustration showing a hand holding a Levemir insulin pen. The image depicts a finger pressing down on the top of the pen, indicating the injection mechanism or operation of the pen device.*

FDA Label Image

Step 9 Fig J.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 36)

An instructional illustration showing a hand holding a Levemir insulin pen, with an arrow indicating to pull or lift a part of the pen upward. A close-up insert focuses on the top of the pen, emphasizing detail of the cap or cartridge area.*

FDA Label Image

Step 10 Fig K.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 37)

Instructional diagram showing how to select insulin dose units on a Levemir insulin pen by Novo Nordisk, with examples of 5 units and 24 units selected. The image highlights turning the dose selector and viewing the units displayed in the dose window.*

FDA Label Image

Step 10 Fig L (Aa947266 E27c 432b 8e04 C36168d24ddb 38)

An illustration showing a syringe-style injection pen partially filled with liquid medication, indicating approximately 200 units remaining. The pen is green with a clear window displaying the liquid level, alongside marking units on the side. The label includes the text 'Example Approx. 200 units left'.*

FDA Label Image

Step 11 Fig M (Aa947266 E27c 432b 8e04 C36168d24ddb 39)

Illustration showing recommended injection sites for Levemir on a human body. Highlighted areas include the upper arm, abdomen, upper thigh, and upper buttocks on both front and back views. The figure helps users identify appropriate locations for subcutaneous injections.*

FDA Label Image

Step 12 Fig N.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 40)

Illustration depicting a hand holding a Levemir insulin pen at a right angle, with an arrow pointing down toward the skin, indicating the injection technique or angle for administering the insulin dose.*

FDA Label Image

Step 13 Fig O.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 41)

An instructional illustration showing a hand holding an injection pen vertically with the needle pointing downwards. An arrow above the hand points downward, and a magnified inset shows a dial indicating the number zero, suggesting a step in the dosage setting or injection process for Levemir.*

FDA Label Image

Step 13 Fig P.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 42)

An instructional illustration showing a hand holding a syringe vertically, with the tip pointing upward. The text bubble says "1-2-3-4-5-6," indicating to count slowly, likely as part of a preparation or injection step. The image is related to Levemir by Novo Nordisk as part of its administration instructions.*

FDA Label Image

Step 14 Fig Q.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 43)

An instructional illustration labeled Figure Q showing a syringe or pen injection device with an upward arrow above it. The image appears to demonstrate the proper needle or cartridge positioning or movement related to the Levemir product.*

FDA Label Image

Step 15 Fig S.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 45)

Illustration showing the step of attaching a component to a syringe, indicated by arrows pointing towards the syringe connector. This instructional diagram is likely part of usage instructions for Levemir by Novo Nordisk.*

FDA Label Image

Step 16 Fig T.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 46)

An instructional diagram showing hands holding a device component with an arrow indicating the removal or twisting of a green cap or ring. The image is related to the use or preparation of the Levemir product device by Novo Nordisk.*

FDA Label Image

Flextouch Qr Code (Aa947266 E27c 432b 8e04 C36168d24ddb 50)

FDA Label Image

Image Of Levemir Vial Carton (Image 01)

An illustration showing the components of the Levemir FlexTouch insulin pen by Novo Nordisk. It labels parts including the pen cap, insulin scale, insulin window, dose counter, dose selector, dose pointer, and dose button, detailing the pen's dose-setting and delivery mechanism.*

FDA Label Image

Flextouch (Image 02)

Box packaging label for Levemir (insulin detemir) injection by Novo Nordisk. The label indicates a strength of 100 units/mL (U-100) for subcutaneous use only, prescription required. It includes instructions for use with U-100 syringes, storage information, and warnings. The packaging is primarily white with blue and green accent panels and contains barcodes and manufacturer details.*

FDA Label Image

Needle Components. (Image 03)

An instructional diagram showing the components of NovoFine, NovoFine Plus, and NovoTwist needle devices used with Levemir. Each device is illustrated with its outer needle cap, inner needle cap, needle, and paper tab, arranged in sequence to demonstrate the parts clearly.*

FDA Label Image

Figure A Flextouch Pen Components. (Image 04)

Levemir FlexTouch insulin degludec injection label showing 100 units/mL concentration in 3 mL prefilled pens. Packaging includes dosage information, usage instructions, and cautionary warnings. Labeler is Novo Nordisk. Visual diagrams illustrate the FlexTouch pen device and pen cap.*

FDA Label Image

Step 15 Figure R (Image 05)

An instructional diagram showing how to use the NovoFine and NovoTwist components of a Levemir insulin delivery pen. The left panel depicts a twisting motion with an arrow pointing left, while the right panel shows a similar twisting motion with an arrow pointing up, illustrating proper pen needle attachment or adjustment.*

FDA Label Image

Figure 2: Activity Profiles In Patients With Type 1 Diabetes (Image 06)

A pharmacodynamic chart for Levemir showing glucose infusion rate (mg/kg/min) over 24 hours after insulin injection at doses of 0.2 and 0.4 Units/kg. The graph includes a table comparing Area Under Curve Glucose Infusion Rate (AUC GIR) and Maximum Glucose Infusion Rate (GIR max) for each dose, with higher values at 0.4 Units/kg.*

FDA Label Image

Figure 3: Activity Profiles In Patients With Type 2 Diabetes (Image 07)

A pharmacodynamic line graph comparing glucose infusion rates (mg/kg/min) over time (hours) after insulin injection for Levemir at doses of 0.6 and 1.2 Units/kg. The graph shows two curves with a table above summarizing area under the curve and maximum glucose infusion rate values for each dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.